Pharmaceutical Excipients Global Market - Forecast to 2022

Publishing Date : September, 2016
Report Code : HCPH 0102
Price:
Single license $4,500
Site license $6,300
Global license $9,000


Pharmaceutical excipients are inactive substances in the drug which helps in modulating solubility, bioavailability and stability of active substances for formulating final drug dosage forms. The excipients form the major part of any medicinal product and proportion of it when compared to Active Pharmaceutical Agent (API) exceeds two to three fold in any pharmaceutical preparations. Hence, various characteristics such as functionality, regulatory status, sources, cost, consistency, bioavailability, physicochemical properties, stability, and pharmacokinetic parameters etc. play a major role in determining the suitability of a substance as an excipient.

As estimated by IQ4I Research the pharmaceutical excipient global market is poised to grow at a mid-range single digit CAGR to reach $7,716 million by 2022. The pharmaceutical excipient market is segmented by source, products, process, functionality, drug dosage forms and finished products. In source excipients market, plant-based excipients held major share and are a fastest growing segment at a CAGR of 7.3%. By-products it is segmented into inorganic chemicals, organic chemicals and pharmaceutical water, among which organic chemicals holds major share and others segment is the fastest growing segment. Inorganic chemicals are further segmented into calcium salts, halites, metallic oxides, silicates and other inorganic chemicals, among which metallic oxides holds a major share of 44.0%. Organic chemicals are further divided into carbohydrates, petrochemicals, oleochemicals, proteins and other organic chemicals, among which carbohydrates holds major share. By process, it is segmented into granulation and direct compression methods. By functionality type, binder & adhesives hold a major share with a strong CAGR of 7.7% from 2015 to 2022. By dosage forms, it is segmented into oral, topical, parenteral and advanced, among which oral dosage forms holds major share and is the fastest growing segment. By finished products, it is segmented into prescription and Over-The-Counter (OTC) products. In finished products segment, prescription drugs held a major share with a strong CAGR of 6.5%. Geography segment is divided into North America, Europe, Asia-Pacific, rest of the world (ROW) where North America holds the largest share of 39.40% and Asia-Pacific is the fastest growing region from 2015 to 2022.


Additionally, top selling pharmaceutical excipient lists are identified. North America holds the largest share in the pharmaceutical excipient market due to rising demand for pharmaceutical and biopharmaceutical drugs and presence of a large number of excipient manufacturers in this region. Europe holds second major share followed by Asia-Pacific and Rest of the World. Asia-Pacific is the fastest growing region where emerging countries such as China and India are the major players due to low labour costs, increased outsourcing of inorganic & organic chemicals manufacturing and increasing governmental spending on health care.


Presently, there is demand for the development of novel excipients with technological advancements like new chemical entity excipients, new chemically modified grade excipients, existing excipients with the various route of administration and co-processed excipients. These novel excipients increase the scope for the development of new formulations and drug delivery system which is a major gain for the industry, but high cost and lengthy developmental process along with the safety and quality issues are delaying the excipients approval. Combination excipients are mostly preferred by the manufacturers as the single excipients do not meet all the functional requirements such as high solubility, stability and bioavailability.

The pharmaceutical excipient global market is a highly competitive market hence all the existing players in this market are involved in developing new and advanced therapeutics to maintain their market shares. Some of the key players contributing at global level for pharmaceutical excipient market growth are Ashland Inc. (U.S.), Associated British Foods Plc (U.K.), Avantor Performance Materials, Inc. (U.S.), BASF SE (Germany), Croda International Plc (U.K.), Dow Chemical Company (U.S.), Evonik Industries AG (Germany), FMC Corporation (U.S.), Lubrizol Corporation (U.S.) and Roquette (France).

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET CRACKDOWN & DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     KEY DATA POINTS FROM SECONDARY RESOURCES
      • 2.5.5     PRIMARY SOURCES
      • 2.5.6     KEY DATA POINT FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     DEVELOPMENT OF MULTIFUNCTIONAL EXCIPIENTS
        • 3.3.1.2     INCREASED DEMAND FOR SOLUBILITY ENHANCING EXCIPIENTS
        • 3.3.1.3     RISING DEMAND FOR SUSTAINED OR CONTROLLED RELEASE FORMULATIONS
        • 3.3.1.4     STRATEGIC PARTNERSHIP/ALLIANCES BY EXCIPIENT MANUFACTURERS
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     LESS INTEREST IN DEVELOPING NOVEL EXCIPIENTS
        • 3.3.2.2     CONTAMINATION IN FORMULATIONS
        • 3.3.2.3     HIGH MARKET FRAGMENTATION WITH LOW-PROFIT MARGINS
        • 3.3.2.4     DEMAND FOR SAFE AND QUALITY EXCIPIENTS BY REGULATORY AUTHORITIES
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     U.S.
      • 3.4.2     EUROPE
      • 3.4.3     ASIA-PACIFIC
      • 3.4.4     REST OF THE WORLD
    • 3.5     PORTER’S FIVE FORCE ANALYSIS
      • 3.5.1     THREAT OF NEW ENTRANTS
      • 3.5.2     THREAT OF SUBSTITUTES
      • 3.5.3     RIVALRY AMONG EXISTING COMPETITORS
      • 3.5.4     BARGAINING POWER OF BUYERS
      • 3.5.5     BARGAINING POWER OF SUPPLIERS
    • 3.6     SUPPLY CHAIN ANALYSIS
    • 3.7     NOVEL EXCIPIENT
    • 3.8     EXCIPIENTS – MOLECULE TYPE
    • 3.9     EXCIPIENTS – AVERAGE SELLING PRICE
    • 3.10     MARKET SHARE ANALYSIS
  • 4     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET, BY SOURCE
    • 4.1     INTRODUCTION
    • 4.2     ANIMAL-BASED EXCIPIENT
    • 4.3     PLANT-BASED EXCIPIENTS
    • 4.4     MINERAL-BASED EXCIPIENTS
    • 4.5     SYNTHETIC-BASED EXCIPIENTS
  • 5     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET, BY PRODUCT
    • 5.1     INTRODUCTION
    • 5.2     INORGANIC CHEMICALS
      • 5.2.1     CALCIUM SALTS
        • 5.2.1.1     CALCIUM PHOSPHATE
        • 5.2.1.2     CALCIUM CARBONATE
        • 5.2.1.3     CALCIUM SULFATE
      • 5.2.2     HALITES
      • 5.2.3     METALLIC OXIDES
      • 5.2.4     SILICATES
      • 5.2.5     OTHERS
    • 5.3     ORGANIC CHEMICALS
      • 5.3.1     CARBOHYDRATES
        • 5.3.1.1     SUGARS
          • 5.3.1.1.1     ACTUAL SUGAR
            • 5.3.1.1.1.1     LACTOSE
            • 5.3.1.1.1.2     SUCROSE
            • 5.3.1.1.1.3     DEXTROSE
          • 5.3.1.1.2     SUGAR ALCOHOL
            • 5.3.1.1.2.1     SORBITOL
            • 5.3.1.1.2.2     MANNITOL
            • 5.3.1.1.2.3     OTHER SUGAR ALCOHOLS
          • 5.3.1.1.3     ARTIFICIAL SWEETENERS
        • 5.3.1.2     STARCH
          • 5.3.1.2.1     MODIFIED STARCH
          • 5.3.1.2.2     DRIED STARCH
          • 5.3.1.2.3     CONVERTED STARCH
        • 5.3.1.3     CELLULOSE
          • 5.3.1.3.1     CELLULOSE ETHERS
          • 5.3.1.3.2     CELLULOSE ESTERS
          • 5.3.1.3.3     CARBOXYMETHYLCELLULOSE SODIUM OR CROSCARMELLOSE SODIUM
          • 5.3.1.3.4     MICROCRYSTALLINE CELLULOSE
      • 5.3.2     PETROCHEMICALS
        • 5.3.2.1     GLYCOL
          • 5.3.2.1.1     POLYETHYLENE GLYCOL
          • 5.3.2.1.2     PROPYLENE GLYCOL
        • 5.3.2.2     POVIDONE
        • 5.3.2.3     MINERAL HYDROCARBONS
          • 5.3.2.3.1     PETROLACTUM
          • 5.3.2.3.2     MINERAL WAXES
          • 5.3.2.3.3     MINERAL OIL
        • 5.3.2.4     ACRYLIC POLYMERS
        • 5.3.2.5     OTHERS
      • 5.3.3     OLEOCHEMICALS
        • 5.3.3.1     FATTY ALCOHOLS
        • 5.3.3.2     METAL STEARATE
        • 5.3.3.3     GLYCERIN
        • 5.3.3.4     OTHERS
      • 5.3.4     PROTEINS
      • 5.3.5     OTHERS
    • 5.4     PHARMA/UNITED STATES PHARMACOPEIA (USP) WATER
      • 5.4.1     WATER FOR INJECTIONS
      • 5.4.2     PURIFIED WATER
  • 6     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET, BY PROCESS
    • 6.1     INTRODUCTION
    • 6.2     GRANULATION
    • 6.3     DIRECT COMPRESSION
  • 7     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET, BY FUNCTIONALITY
    • 7.1     INTRODUCTION
    • 7.2     FILLERS & DILUENTS
    • 7.3     BINDERS & ADHESIVES
    • 7.4     SUSPENSION & VISCOSITY AGENTS
    • 7.5     COATINGS
    • 7.6     FLAVORING AGENTS & SWEETENERS, COLORANTS
    • 7.7     DISINTEGRANTS
    • 7.8     LUBRICANTS & GLIDANTS
    • 7.9     PRESERVATIVES
    • 7.1     SOLUBILIZER
    • 7.11     SOLVENTS
    • 7.12     OTHERS
  • 8     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET, BY DOSAGE FORMS
    • 8.1     INTRODUCTION
    • 8.2     ORAL
      • 8.2.1     TABLETS
      • 8.2.2     CAPSULES
        • 8.2.2.1     HARD GELATIN CAPSULE
        • 8.2.2.2     SOFT GELATIN CAPSULE
      • 8.2.3     LIQUIDS
    • 8.3     TOPICAL
    • 8.4     PARENTERAL
    • 8.5     ADVANCED DRUG DOSAGE FORM
  • 9     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET, BY FINISHED PRODUCTS
    • 9.1     INTRODUCTION
    • 9.2     PRESCRIPTION DRUG
    • 9.3     OVER-THE-COUNTER (OTC) DRUGS
  • 10     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET, BY GEOGRAPHY
    • 10.1     INTRODUCTION
    • 10.2     NORTH AMERICA
    • 10.3     EUROPE
    • 10.4     ASIA-PACIFIC
    • 10.5     REST OF THE WORLD
  • 11     COMPETITIVE LANDSCAPE
    • 11.1     INTRODUCTION
    • 11.2     APPROVALS
    • 11.3     NEW PRODUCT LAUNCHES
    • 11.4     BUSINESS EXPANSIONS
    • 11.5     AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES
  • 12     COMPANY PROFILES
    • 12.1     ASHLAND, INC
      • 12.1.1     OVERVIEW
      • 12.1.2     FINANCIALS
      • 12.1.3     PRODUCT PORTFOLIO
      • 12.1.4     KEY DEVELOPMENTS
      • 12.1.5     BUSINESS STRATEGY
      • 12.1.6     SWOT ANALYSIS
    • 12.2     ASSOCIATED BRITISH FOODS PLC
      • 12.2.1     OVERVIEW
      • 12.2.2     FINANCIALS
      • 12.2.3     PRODUCT PORTFOLIO
      • 12.2.4     KEY DEVELOPMENTS
      • 12.2.5     BUSINESS STRATEGY
      • 12.2.6     SWOT ANALYSIS
    • 12.3     AVANTOR PERFORMANCE MATERIALS
      • 12.3.1     OVERVIEW
      • 12.3.2     FINANCIALS
      • 12.3.3     PRODUCT PORTFOLIO
      • 12.3.4     KEY DEVELOPMENTS
      • 12.3.5     BUSINESS STRATEGY
      • 12.3.6     SWOT ANALYSIS
    • 12.4     BASF SE
      • 12.4.1     OVERVIEW
      • 12.4.2     FINANCIALS
      • 12.4.3     PRODUCT PORTFOLIO
      • 12.4.4     KEY DEVELOPMENTS
      • 12.4.5     BUSINESS STRATEGY
      • 12.4.6     SWOT ANALYSIS
    • 12.5     CRODA INTERNATIONAL PLC
      • 12.5.1     OVERVIEW
      • 12.5.2     FINANCIALS
      • 12.5.3     PRODUCT PORTFOLIO
      • 12.5.4     KEY DEVELOPMENTS
      • 12.5.5     BUSINESS STRATEGY
      • 12.5.6     SWOT ANALYSIS
    • 12.6     DOW CHEMICAL COMPANY
      • 12.6.1     OVERVIEW
      • 12.6.2     FINANCIALS
      • 12.6.3     PRODUCT PORTFOLIO
      • 12.6.4     KEY DEVELOPMENTS
      • 12.6.5     BUSINESS STRATEGY
      • 12.6.6     SWOT ANALYSIS
    • 12.7     EVONIK INDUSTRIES AG
      • 12.7.1     OVERVIEW
      • 12.7.2     FINANCIALS
      • 12.7.3     PRODUCT PORTFOLIO
      • 12.7.4     KEY DEVELOPMENTS
      • 12.7.5     BUSINESS STRATEGY
      • 12.7.6     SWOT ANALYSIS
    • 12.8     FMC CORPORATION
      • 12.8.1     OVERVIEW
      • 12.8.2     FINANCIALS
      • 12.8.3     PRODUCT PORTFOLIO
      • 12.8.4     KEY DEVELOPMENTS
      • 12.8.5     BUSINESS STRATEGY
      • 12.8.6     SWOT ANALYSIS
    • 12.9     LUBRIZOL CORPORATION
      • 12.9.1     OVERVIEW
      • 12.9.2     FINANCIALS
      • 12.9.3     PRODUCT PORTFOLIO
      • 12.9.4     KEY DEVELOPMENTS
      • 12.9.5     BUSINESS STRATEGY
      • 12.9.6     SWOT ANALYSIS
    • 12.10     ROQUETTE
      • 12.10.1     OVERVIEW
      • 12.10.2     FINANCIALS
      • 12.10.3     PRODUCT PORTFOLIO
      • 12.10.4     KEY DEVELOPMENTS
      • 12.10.5     BUSINESS STRATEGY
      • 12.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 2     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY SOURCE, (2014-2022) ($MN)
      • TABLE 3     ANIMAL-BASED PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 4     PLANT-BASED PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 5     MINERAL-BASED PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 6     SYNTHETIC-BASED PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 7     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
      • TABLE 8     INORGANIC CHEMICAL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 9     INORGANIC CHEMICAL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 10     CALCIUM SALTS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 11     CALCIUM SALTS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 12     CALCIUM PHOSPHATE PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 13     CALCIUM CARBONATE PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 14     OTHERS CALCIUM SALTS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 15     HALITES PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 16     METALLIC OXIDES PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 17     SILICATES PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 18     OTHER INORGANIC CHEMICALS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 19     ORGANIC CHEMICAL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 20     ORGANIC CHEMICAL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 21     CARBOHYDRATE PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 22     CARBOHYDRATE PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 23     SUGAR PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 24     SUGAR PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 25     ACTUAL SUGAR PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 26     ACTUAL SUGAR PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 27     LACTOSE PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 28     SUCROSE PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 29     DEXTROSE PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 30     SUGAR ALCOHOL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 31     SORBITOL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 32     MANNITOL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 33     OTHER SUGAR ALCOHOLS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 34     ARTIFICIAL SWEETENER PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 35     STARCH PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 36     STARCH PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 37     MODIFIED STARCH PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 38     DRIED STARCH PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
      • TABLE 39     CONVERTED STARCH PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 40     CELLULOSE PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 41     CELLULOSE PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 42     CELLULOSE ETHERS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
      • TABLE 43     CELLULOSE ESTERS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 44     CROSCARMELLOSE SODIUM PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 45     MICROCRYSTALLINE CELLULOSE PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 46     PETROCHEMICAL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 47     PETROCHEMICAL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 48     GLYCOL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 49     GLYCOL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 50     POLYETHYLENE GLYCOL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 51     PROPYLENE GLYCOL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 52     POVIDONE PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 53     MINERAL HYDROCARBONS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 54     ACRYLIC POLYMERS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 55     OTHER PETROCHEMICALS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 56     OLEOCHEMICALS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 57     OLEOCHEMICALS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 58     FATTY ALCOHOLS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 59     METAL STEARATES PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 60     GLYCERIN PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 61     OTHER OLEOCHEMICAL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 62     PROTEIN PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 63     OTHER ORGANIC CHEMICALS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 64     PHARMA/USP WATER PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 65     PHARMA/USP WATER PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 66     WATER FOR INJECTIONS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 67     PURIFIED WATER PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 68     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY PROCESS, (2014-2022) ($MN)
      • TABLE 69     GRANULATION PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 70     DIRECT COMPRESSION PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 71     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY FUNCTIONALITY, (2014-2022) ($MN)
      • TABLE 72     FILLER & DILUENT PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 73     BINDER & ADHESIVE PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 74     SUSPENSION & VISCOSITY AGENTS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 75     COATING PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 76     COLORANTS, SWEETENERS & FLAVOURING AGENTS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 77     DISINTEGRANTS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 78     LUBRICANTS & GLIDANTS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 79     PRESERVATIVE PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 80     SOLUBILIZER PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 81     SOLVENT/CO-SOLVENTS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 82     OTHER FUNCTIONALITY PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 83     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY DOSAGE FORMS, (2014-2022) ($MN)
      • TABLE 84     ORAL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 85     ORAL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 86     TABLET PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 87     CAPSULE PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 88     LIQUID PHARMACEUTICAL EXCIPIENT MARKETS GLOBAL REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 89     TOPICAL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 90     PARENTERAL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 91     ADVANCED DRUG DOSAGE PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 92     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY FINISHED PRODUCTS, (2014-2022) ($MN)
      • TABLE 93     PRESCRIPTION DRUGS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 94     OTC DRUGS PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 95     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 96     NORTH AMERICAN PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE, (2014-2022) ($MN)
      • TABLE 97     NORTH AMERICAN PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
      • TABLE 98     NORTH AMERICAN INORGANIC CHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 99     NORTH AMERICAN CALCIUM SALT PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 100     NORTH AMERICAN ORGANIC CHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 101     NORTH AMERICAN CARBOHYDRATES PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 102     NORTH AMERICAN SUGAR PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 103     NORTH AMERICAN ACTUAL SUGAR PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 104     NORTH AMERICAN SUGAR ALCOHOL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 105     NORTH AMERICAN STARCH PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 106     NORTH AMERICAN CELLULOSE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 107     NORTH AMERICAN PETROCHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 108     NORTH AMERICAN GLYCOL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 109     NORTH AMERICAN OLEOCHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 110     NORTH AMERICAN OTHERS PHARMA/USP WATER PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 111     NORTH AMERICAN PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY PROCESS, (2014-2022) ($MN)
      • TABLE 112     NORTH AMERICAN PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTIONALITY, (2014-2022) ($MN)
      • TABLE 113     NORTH AMERICAN PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY DOSAGE FORMS, (2014-2022) ($MN)
      • TABLE 114     NORTH AMERICAN ORAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 115     NORTH AMERICAN PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FINISHED PRODUCTS, (2014-2022) ($MN)
      • TABLE 116     EUROPEAN PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE, (2014-2022) ($MN)
      • TABLE 117     EUROPEAN PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
      • TABLE 118     EUROPEAN INORGANIC CHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 119     EUROPEAN CALCIUM SALT PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 120     EUROPEAN ORGANIC CHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 121     EUROPEAN CARBOHYDRATES PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 122     EUROPEAN SUGAR PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 123     EUROPEAN ACTUAL SUGAR PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 124     EUROPEAN SUGAR ALCOHOL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 125     EUROPEAN STARCH PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 126     EUROPEAN CELLULOSE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 127     EUROPEAN PETROCHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 128     EUROPEAN GLYCOL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 129     EUROPEAN OLEOCHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 130     EUROPEAN OTHERS PHARMA/USP WATER PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 131     EUROPEAN PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY PROCESS, (2014-2022) ($MN)
      • TABLE 132     EUROPEAN PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTIONALITY, (2014-2022) ($MN)
      • TABLE 133     EUROPEAN PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY DOSAGE FORMS, (2014-2022) ($MN)
      • TABLE 134     EUROPEAN ORAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 135     EUROPEAN PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FINISHED PRODUCTS, (2014-2022) ($MN)
      • TABLE 136     ASIA-PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE, (2014-2022) ($MN)
      • TABLE 137     ASIA-PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
      • TABLE 138     ASIA-PACIFIC INORGANIC CHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 139     ASIA-PACIFIC CALCIUM SALT PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 140     ASIA-PACIFIC ORGANIC CHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 141     ASIA-PACIFIC CARBOHYDRATES PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 142     ASIA-PACIFIC SUGAR PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 143     ASIA-PACIFIC ACTUAL SUGAR PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 144     ASIA-PACIFIC SUGAR ALCOHOL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 145     ASIA-PACIFIC STARCH PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 146     ASIA-PACIFIC CELLULOSE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 147     ASIA-PACIFIC PETROCHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 148     ASIA-PACIFIC GLYCOL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 149     ASIA-PACIFIC OLEOCHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 150     ASIA-PACIFIC OTHERS PHARMA/USP WATER PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 151     ASIA-PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY PROCESS, (2014-2022) ($MN)
      • TABLE 152     ASIA-PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTIONALITY, (2014-2022) ($MN)
      • TABLE 153     ASIA-PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY DOSAGE FORMS, (2014-2022) ($MN)
      • TABLE 154     ASIA-PACIFIC ORAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 155     ASIA-PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FINISHED PRODUCTS, (2014-2022) ($MN)
      • TABLE 156     ROW PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE, (2014-2022) ($MN)
      • TABLE 157     ROW PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
      • TABLE 158     ROW INORGANIC CHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 159     ROW CALCIUM SALT PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 160     ROW ORGANIC CHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 161     ROW CARBOHYDRATES PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 162     ROW SUGAR PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 163     ROW ACTUAL SUGAR PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 164     ROW SUGAR ALCOHOL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 165     ROW STARCH PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 166     ROW CELLULOSE PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE (2014-2022) ($MN)
      • TABLE 167     ROW PETROCHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 168     ROW GLYCOL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 169     ROW OLEOCHEMICAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 170     ROW OTHERS PHARMA/USP WATER PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE (2014-2022) ($MN)
      • TABLE 171     ROW PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY PROCESS, (2014-2022) ($MN)
      • TABLE 172     ROW PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FUNCTIONALITY, (2014-2022) ($MN)
      • TABLE 173     ROW PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY DOSAGE FORMS, (2014-2022) ($MN)
      • TABLE 174     ROW ORAL PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 175     ROW PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY FINISHED PRODUCTS, (2014-2022) ($MN)
      • TABLE 176     APPROVALS (2014-2016)
      • TABLE 177     NEW PRODUCT LAUNCHES (2014-2016)
      • TABLE 178     BUSINESS EXPANSIONS (2014-2016)
      • TABLE 179     AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES (2014-2016)
      • TABLE 180     ASHLAND, INC.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 181     ASHLAND, INC.: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 182     ASHLAND, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 183     ASSOCIATED BRITISH FOODS PLC: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 184     ASSOCIATED BRITISH FOODS PLC: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 185     ASSOCIATED BRITISH FOODS PLC: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 186     BASF SE: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 187     BASF SE: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 188     BASF SE: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 189     CRODA INTERNATIONAL PLC: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 190     CRODA INTERNATIONAL PLC: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 191     CRODA INTERNATIONAL PLC: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 192     DOW CHEMICAL CO: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 193     DOW CHEMICAL CO: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 194     DOW CHEMICAL CO: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 195     EVONIK INDUSTRIES AG: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 196     EVONIK INDUSTRIES AG: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 197     EVONIK INDUSTRIES AG: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 198     FMC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 199     FMC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 200     FMC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)

      LIST OF FIGURES

      • FIGURE 1     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET
      • FIGURE 3     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET: MARKET CRACKDOWN & DATA TRIANGULATION
      • FIGURE 6     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET: MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET, BASED-ON MOLECULE TYPE (2015) (%)
      • FIGURE 11     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET, BASED-ON SMALL MOLECULE
      • FIGURE 12     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET, BASED-ON LARGE MOLECULE
      • FIGURE 13     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015, (%)
      • FIGURE 14     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY SOURCE, (2015 V’S 2022) ($MN)
      • FIGURE 15     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY PRODUCTS, (2015 V’S 2022) ($MN)
      • FIGURE 16     INORGANIC CHEMICAL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2015) ($MN)
      • FIGURE 17     ORGANIC CHEMICAL PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • FIGURE 18     CARBOHYDRATES PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2015) ($MN)
      • FIGURE 19     STARCH PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY TYPE, (2015 V’S 2022) ($MN)
      • FIGURE 20     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY PROCESS, (2015 V’S 2022) ($MN)
      • FIGURE 21     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY FUNCTIONALITY, (2015) ($MN)
      • FIGURE 22     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY DOSAGE FORMS, (2015) ($MN)
      • FIGURE 23     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET REVENUE, BY FINISHED PRODUCTS, (2014-2022) ($MN)
      • FIGURE 24     PHARMACEUTICAL EXCIPIENTS GLOBAL MARKET SCENARIO, BY REGION, (2014 - 2022) ($MN), CAGR (%)
      • FIGURE 25     NORTH AMERICAN PHARMECUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE, PRODUCT, FUNCTIONALITY, PROCESS AND DOSAGE FORMS (2015 V’S 2022) ($MN)
      • FIGURE 26     EUROPEAN PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE, PRODUCTS, FUNCTIONALITY, PROCESS AND DOSAGE FORMS, (2015 V’S 2022) ($MN)
      • FIGURE 27     ASIA-PACIFIC PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE, PRODUCT, FUNCTIONALITY, PROCESS AND DOSAGE FORMS, (2015 V’S 2022) ($MN)
      • FIGURE 28     ROW PHARMACEUTICAL EXCIPIENTS MARKET REVENUE, BY SOURCE, PRODUCTS, FUNCTIONALITY, PROCESS AND DOSAGE FORMS, (2015 V’S 2022) ($MN)
      • FIGURE 29     KEY GROWTH STRATEGIES, (2014 – 2016)
      • FIGURE 30     SWOT: ASHLAND, INC
      • FIGURE 31     SWOT: SPI PHARMA
      • FIGURE 32     SWOT: AVANTOR PERFORMANCE MATERIALS
      • FIGURE 33     SWOT: BASF SE
      • FIGURE 34     SWOT: CRODA INTERNATIONAL PLC
      • FIGURE 35     SWOT: DOW CHEMICAL CO
      • FIGURE 36     SWOT: EVONIK INDUSTRIES AG
      • FIGURE 37     SWOT: FMC CORPORATION
      • FIGURE 38     SWOT: LUBRIZOL CORPORATION
      • FIGURE 39     SWOT: ROQUETTE

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     ADORE PHARMACEUTICALS PVT. LTD.
      • 2     ALSIANO
      • 3     ARCHER DANIELS MIDLAND COMPANY
      • 4     ARMOUR PHARMACEUTICALS LTD
      • 5     ASAHI KASEI CHEMICALS
      • 6     ASHLAND, INC.
      • 7     ASSOCIATED BRITISH FOOD INC
      • 8     AVANTOR PERFORMANCE MATERIALS
      • 9     AZELIS PHARMA
      • 10     BASF SE
      • 11     CABOT CORPORATION
      • 12     CAPSUGEL
      • 13     CAPTEK
      • 14     CARGILL
      • 15     CELANESE CORPORATION
      • 16     CHELLCHEM PHARMACEUTICAL INC
      • 17     CHEMISCHE FABRIK BUDENHEIM
      • 18     COLORCON
      • 19     CORDEN PHARMA
      • 20     COREL PHARMA CHEM
      • 21     CRODA INTERNATIONAL PLC
      • 22     DFE PHARMA
      • 23     DONGBAO BIO-TECH
      • 24     DOW CHEMICAL CO
      • 25     EASTMAN CHEMICAL CO.
      • 26     ELETTRACQUA
      • 27     EMD MILLIPORE
      • 28     ERAWAT PHARMA LIMITED
      • 29     ER-KANG PHARMACEUTICAL
      • 30     EURO LIFE HEALTHCARE PVT LTD
      • 31     EVONIK INDUSTRIES AG
      • 32     FINAR CHEMICALS LIMITED
      • 33     FMC BIOPOLYMER
      • 34     FMC CORPORATION
      • 35     FMC HEALTH & NUTRITION
      • 36     FUCHS LUBRICANTS
      • 37     FUJI CHEMICAL INDUSTRY CO LTD
      • 38     GLOBAL MERCHANTS
      • 39     GUANGXI NANNING CHEMICAL PHARMACEUTICAL CO LTD
      • 40     HUBER ENGINEERED MATERIALS
      • 41     INGREDION INCORPORATED
      • 42     INNOPHOS
      • 43     J.M. HUBER CORPORATION
      • 44     JRS PHARMA
      • 45     KERRY GROUP
      • 46     KIRSCH PHARMA
      • 47     LACTOSE INDIA LTD
      • 48     LUBRIZOL CORPORATION
      • 49     MARTINDALE
      • 50     MEGGLE PHARMA
      • 51     MERCK MILLIPORE
      • 52     MINERAL TECHNOLOGIES INC.
      • 53     MINGTAI CHEMICAL CO. LTD.
      • 54     MUBY CHEMICALS
      • 55     MUTCHLER
      • 56     NITIKA PHARMACEUTICAL SPECIALITIES PVT LTD
      • 57     NOVATIS CONSUMER HEALTH
      • 58     OMYA PHARMACEUTICALS
      • 59     PERRIGO
      • 60     PFANSTIEHL
      • 61     PFIZER
      • 62     PIERRE FABRE
      • 63     PROSTRAKAN
      • 64     QINGHAI GELATIN CO. LTD.
      • 65     QUFU TIANLI
      • 66     RANQ REMEDIES PVT LTD
      • 67     ROQUETTE
      • 68     SAFC PHARMA
      • 69     SELECTCHEMIE
      • 70     SEPPIC
      • 71     SERUM PRODUCT GROUP
      • 72     SHANDONG LIAOCHENG E HUA PHARMACEUTICAL
      • 73     SHREEJI PHARMA INTERNATIONAL
      • 74     SIGACHI
      • 75     SIGNET
      • 76     SPIROCHEM AG
      • 77     STROEVER GMBH & CO. KG
      • 78     SUNHERE PHARMACEUTICAL EXCIPIENTS
      • 79     TAKEDA
      • 80     TEREOS STARCH & SWEETENERS
      • 81     TIRUPATI INDUSTRIES
      • 82     UNIVAR
      • 83     VIKRAM THERMO LTD.
      • 84     WARNER CHILCOTT
      • 85     ZHANWANG PHARMACEUTICAL
      • 86     ZUCHEM